Sotelo, Miguel Jhonatan <br/><br/>
Role of cetuximab in first-line treatment of metastatic colorectal cancer.  [electronic resource] 

 -  World journal of gastroenterology  Apr 2014 
 - 4208-19 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2219-2840 
<br/><br/><label>Standard No.: </label>10.3748/wjg.v20.i15.4208  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Camptothecin--analogs & derivatives<br/>Cetuximab<br/>Clinical Trials as Topic<br/>Colorectal Neoplasms--drug therapy<br/>ErbB Receptors--metabolism<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Leucovorin--therapeutic use<br/>Ligands<br/>Liver Neoplasms--secondary<br/>Mutation<br/>Neoplasm Metastasis<br/>Organoplatinum Compounds--therapeutic use<br/>Oxaliplatin<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--metabolism<br/>ras Proteins--genetics